IFLIT
CLB icon

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV’s Core Laboratories CLB Stock Holding History

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,000
Closed -$155K – 19
2020
Q1 		$155K Buy
+15,000
New +$420K 0.02% 20

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV's CLB Position: Q2 2020 in Review

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV sold out of Core Laboratories (CLB) in Q2 2020, closing a stake of 15,000 shares — an estimated $155K sold.

Investmentaktiengesellschaft Fuer Langfristige Investoren TGV first reported a position in CLB in Q1 2020 and held it in 1 quarter. The position peaked at $155K in Q1 2020. 197 funds tracked by Wall St. Rank hold CLB as of Q2 2020.

  • Investmentaktiengesellschaft Fuer Langfristige Investoren TGV reported no remaining Core Laboratories position as of Q2 2020 after selling out during the quarter.
  • Investmentaktiengesellschaft Fuer Langfristige Investoren TGV sold 15,000 Core Laboratories shares in Q2 2020, an estimated $155K.
  • Investmentaktiengesellschaft Fuer Langfristige Investoren TGV first reported a position in Core Laboratories in Q1 2020 and held it in 1 quarter.
  • Investmentaktiengesellschaft Fuer Langfristige Investoren TGV's Core Laboratories position peaked at $155K in Q1 2020.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2020.

Based on Investmentaktiengesellschaft Fuer Langfristige Investoren TGV's 13F filing for Q2 2020, filed 16 Jul 2020.